AmChamSG Commemorates Martin Luther King, Jr., National Day of Service with St Luke’s ElderCare at the Singapore Flyer

SINGAPORE, Jan. 21, 2025 /PRNewswire/ — The American Chamber of Commerce in Singapore (AmChamSG) is donating $5,000 to the California wildfires relief, as well as SGSHARE, a national regular giving program by the Community Chest in conjunction with SG60 to rally Singapore to support communities in need. The funds were raised at a farewell dinner honoring U.S. Ambassador to Singapore H.E. Jonathan E. Kaplan in the lead up to Martin Luther King, (MLK) Jr., Day of Service.

AmChamSG volunteers also spent MLK Jr. Day with elders from St Luke’s ElderCare on their first visit to the Singapore Flyer, providing an enriching experience and fostering meaningful connections. A federal holiday in the U.S., MLK Jr. Day was first observed in 1986 in memory of the civil rights hero. Since 1994, Americans have been encouraged to commemorate the day through acts of service.

Dr. Hsien-Hsien Lei, Chief Executive Officer of AmChamSG said, “We have been volunteering on MLK Jr. Day since 2021. In the words of Dr. Martin Luther King, Jr., ‘Everyone can be great, because everyone can serve.’

An AmChamSG strategic pillar, Community is at the heart of our member companies’ purpose. Amidst global uncertainty, AmChamSG member companies, including CSR partners Micron and West Pharmaceutical Services, remain committed to the economic and social development of Singapore.”

About AmCham Singapore

Established in 1973, the American Chamber of Commerce in Singapore (AmCham Singapore) is the largest and the most active international business association in Singapore and Southeast Asia, with nearly 700 member companies.

Our Chamber comprises 12 industry-specific committees: five sectoral and seven functional. AmCham is a forward-thinking, business-progressive association. Our mission is to create value for our members by providing advocacy, thought leadership, and community. Our membership includes American companies and Singaporean and third-country companies with significant U.S. business interests.

AmCham is an independent, non-partisan business organization. Our goal is to provide the information and facilitate the access and connections that give members insight into the local, regional, and global operating environment, enhance their professional capabilities, and enable them to make well informed business decisions.

www.amcham.com.sg

SINGAPORE, Jan. 21, 2025 /PRNewswire/ — dss⁺ announced today strategic leadership changes to its Executive Leadership Team (ELT) in Asia Pacific. These changes support the company’s goals to accelerate impact on clients, develop internal talent, and deliver on its purpose of saving lives and creating a sustainable future in the region.

“We remain committed to growing our leaders and providing new development experiences, while leveraging their experiences to help our clients achieve breakthroughs in operational safety, performance and sustainability that drive lasting success,” said Davide Vassallo, CEO of dss⁺. “These leadership changes will further strengthen our growth trajectory and evolution of our firm.”

Advancing Growth in Asia Pacific’s Dynamic Markets

The Asia Pacific region remains a critical driver of global economic expansion, contributing approximately 60% of global growth in 2024, according to the International Monetary Fund (IMF). With a projected GDP growth of 4.4% in 2025 — outpacing the global average — the region continues to demonstrate remarkable economic resilience.

As a critical hub for heavy industries, dss⁺ observes significant developments across key sectors where the company has been actively expanding its operational excellence capabilities. The region is experiencing transformative changes in petrochemicals, energy, industrial manufacturing, and infrastructure. Major economies such as China, India, Australia, Japan, and some Southeast Asian nations are advancing strategically in industrial transformation, focusing on sustainable manufacturing, advanced petrochemical capabilities, and building resilient supply chains and infrastructure.

Key leadership appointments in Asia Pacific

Srinivasan Ramabhadran elevates his role to Managing Director and dss⁺ Board member. In this new position, Ramabhadran will focus on global growth initiatives aligned with the organisation’s strategy while continuing to lead key accounts in the Asia Pacific region.

With over 22 years at dss⁺, Srinivasan built the consulting team across Asia Pacific and previously held roles including global practice leader for Operations Risk Management and market leader for India and ASEAN. He has developed trusted client relationships globally and has been instrumental in building the dss⁺ brand.

“I am honoured to shape and drive dss⁺’s global growth strategy,” said Srinivasan. “The Asia Pacific region has been at the forefront of driving resilient growth, and I look forward to leveraging our regional insights and deep expertise to help organizations transform their operational performance and create lasting impact.”

Cedric Parentelli is appointed Managing Director, Asia Pacific, focusing on delivering superior impact and value to clients in the region. He will reinforce the industry focus and embed deep transformational expertise in client organizations to ensure sustainable results.

Cedric, who began his career with dss⁺ nine years ago, previously led the Western, Central Europe and North Africa region, later expanding his responsibilities to lead Europe, the Middle East and Africa. He built structural foundations to support the brand’s global strategy and focused on leveraging consulting capabilities and industry expertise to deliver strategic solutions to clients.

“The Asia Pacific region is a powerhouse of industrial and economic transformation, presenting both challenges and opportunities in high-hazard, complex industries,” Cedric commented. “I am confident in the region’s growth potential. We aim to help organizations turn operational risks into strategic advantages, elevating performance sustainably.”

These leadership changes position dss⁺ to better serve its clients in Asia Pacific, driving growth and delivering impactful solutions in operational safety, performance, and sustainability across the region’s diverse and rapidly evolving markets.

About dss⁺

dss⁺ is the operational transformation partner for complex and high-hazard industries. We help organisations achieve breakthroughs in safety, performance and sustainability that drive lasting success.

Combining deep technical expertise and decades of hands-on experience with cutting-edge methodologies and data-driven insights, we empower teams to shift mindsets, shape cultures and build the capabilities needed at every level.  www.consultdss.com

NEW DELHI, Jan. 21, 2025 /PRNewswire/ — Ampace, a global leader in lithium-ion battery solutions, is proud to announce the official launch of our new E30P cell at the 2025 Bharat Battery Show, held from January 19-21, marking a significant step in advancing green mobility solutions in India. On January 19, Ampace introduced E30P officially, bringing cutting-edge battery technology to India’s rapidly growing electric two-wheeler market.

Addressing India’s EV Market Needs: Bridging the Gap Between Performance, Long life and Economy

India is experiencing rapid growth in electric vehicle adoption, particularly in the two-wheeler segment. Electric motorcycles and scooters have become increasingly popular for their eco-friendly benefits and convenience, catering to a wide range of applications from daily commuting to food delivery. However, one of the biggest challenges facing the sector is the balance between higher performance, longer life and better economy in battery technology.

The E30P is designed specifically to address these challenges, offering a battery solution that delivers both high performance and long endurance, meeting the unique demands of the Indian market. With a focus on electric two-wheelers, the E30P provides an optimal balance between performance, reliability, and economy.

E30P: The Power of Innovation — “Easy to Go”

The E30P, featuring Ampace’s proprietary BP (Boost Power) system, is a breakthrough in battery technology. The BP system improves energy density and safety by using advanced materials in the cathode, anode, and graphite, allowing for faster deintercalation of lithium ions and lower energy consumption. This results in superior power, longer battery life, and enhanced safety.

Rajeev Prasad, Ampace’s Director of India Market Sales, addressed the audience during the product launch, saying, “The E30P stands for endurance, capacity, and power — form the foundation of the E30P. This isn’t just a name; it’s a promise of reliable, high-performing energy storage that empowers customers to achieve more. We are excited to introduce the E30P to India, a solution that is tailored to meet the needs of electric two-wheelers in the country.”

The E30P battery comes in a standardized 35205 cylindrical cell size, with a 35mm diameter and 205mm height. This size is optimized for mainstream electric motorcycles and scooters in India, ensuring that the battery packs fit a variety of models including motorcycles, scooters, and maxi-scooters.

Diverse Compatibility to Meet Various Needs:

The E30P cell, with its 30Ah capacity and 35205 dimensions, is highly suitable for electric two-wheeler battery packs in the Indian market. Whether for standard motorcycles, scooters, or underbone models, its flexible battery pack design can adapt to different application scenarios.

Outstanding Range and High Performance:

The E30P cell supports multiple battery solutions, such as a 1.5kWh battery for daily commuting, a 3kWh battery for delivery services, and high-capacity, high-power batteries for long-range, high-speed electric motorcycles. It meets a wide range of range and performance requirements.

Economical and Efficiency Gains:

Compared to traditional 21700 cells, the E30P offers a 600% increase in capacity. This allows for a more streamlined battery pack design, reducing welding points and  component usage. As a result, it lowers the design and manufacturing costs of the pack while improving product reliability.

Ultimate Safety to Ensure User Experience:

The E30P cell incorporates Ampace’s BP technology system, providing high thermal stability and effectively preventing thermal runaway issues. Additionally, the cell has undergone rigorous mechanical performance testing and safety certifications to ensure exceptional safety in extreme environments and applications.

Fast Charging to Enhance User Experience:

The E30P supports both daily fast charging and emergency quick charging scenarios. It can charge to 95% in just 47 minutes under daily fast charging conditions, and up to 50% in only 15 minutes during emergency charging, significantly enhancing user convenience.

Future Outlook: Empowering India’s Green Mobility Revolution

Looking forward, Ampace is committed to furthering the development of India’s green mobility sector. As electric two-wheelers continue to grow in popularity, the E30P represents a significant step toward improving the performance, economy, and sustainability of electric vehicles in India.

Ampace’s entry into the Indian market with the E30P battery cell is expected to play a pivotal role in shaping the future of electric two-wheelers in India, offering powerful, reliable, and safe solutions that meet the diverse needs of Indian consumers and businesses.

CAIRO, Jan. 21, 2025 /PRNewswire/ — Envision Energy, a global leader in in green technology, has secured a landmark contract for Saudi developer and world largest private company in water desalination, leader in energy transition and first mover into green hydrogen, ACWA Power’s 1.1GW onshore wind farm in Egypt’s Gulf of Suez region, set to become one of the largest in the Middle East and North Africa (MENA) region. This groundbreaking collaboration will significantly enhance Egypt’s renewable energy capacity, supporting the country and MENA’s energy transition and sustainable development goals.

The project is managed by Suez Wind Energy, a joint venture by Saudi Arabia’s ACWA Power and HAU Energy, with financing provided by the European Bank for Reconstruction and Development (EBRD). It will feature 138 of Envision Energy’s state-of-the-art 8 MW wind turbines, designed for high wind speeds and sandy environments and include 25 years of long-term maintenance services, ensuring optimal performance and reliability throughout its lifespan.

“We are thrilled to be part of this transformative project in Egypt. By leveraging our cutting-edge turbine technology and industry-leading supply chain integration, this project will set a new standard for large-scale wind energy in the MENA region.” said Kane Xu, Senior Vice President and President of International Product Lines at Envision Energy, “As the world accelerates its transition to cleaner energy, this project highlights the power of innovation and collaboration to scale sustainability. It underscores our commitment to delivering tailored solutions that meet the unique challenges of renewable energy deployment in diverse environments.”

Envision Energy’s 8 MW platform turbines are customizable with different blade configurations and hub heights to optimize energy capture in diverse conditions. Backed by Envision’s industry-leading vertical supply chain integration and in-house development and manufacturing of critical components, these turbines offer superior quality and reliability. Additionally, the use of Envision’s Galileo system, which analyzes real-time wind data to define precise load conditions for component- and system-level testing, ensures unmatched performance.

This project marks a significant milestone in the MENA region’s clean energy journey, offering broad economic and environmental benefits. It will enhance Egypt’s renewable energy infrastructure, attract further investment, drive innovation, and create job opportunities. By setting a new benchmark for large-scale renewable energy projects, the wind farm underscores Envision Energy’s commitment to advancing the global energy transition and lays the foundation for future collaborations worldwide.

TAIPEI, Jan. 21, 2025 /PRNewswire/ — TAHO Pharmaceuticals is pleased to announce the successful completion of the pivotal trial for TAH3311, the first anticoagulant oral dissolving film (ODF). This trial was conducted following detailed discussions and alignment with the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), marking a major milestone in the advancement of this innovative product under the 505(b)(2) regulatory pathway.

The trial enrolled 60 healthy volunteers to compare TAH3311 ODF with the Apixaban tablet (brand name Eliquis®) under the bioequivalence (BE) regulatory framework. Apixaban, a Factor Xa inhibitor, is widely used for stroke prevention and treatment of thromboembolic conditions due to its lower dosage requirements and reduced gastrointestinal bleeding risk compared to other anticoagulants. TAH3311 addresses a significant unmet need in this market by offering the first ODF formulation, providing a water-free alternative that is especially beneficial for patients with swallowing difficulties, including the elderly, stroke survivors, and children.

According to IQVIA, the global market for anticoagulants is rapidly expanding, with apixaban achieving U.S. sales of $22.1 billion in 2023, making it the leading small-molecule drug globally and the second best-selling drug overall.* This remarkable growth highlights a significant opportunity for TAH3311 to address existing clinical unmet needs while offering a unique differentiation in an increasingly competitive landscape.

With the trial’s completion, TAHO Pharmaceuticals plans to prepare regulatory submissions in both the United States and Europe. Simultaneously, the company is actively pursuing strategic collaborations with international partners to accelerate the global launch of TAH3311 and maximize its impact in key markets.

“The completion of this pivotal study is a significant step forward in TAHO’s mission to bring innovative Transepithelial Delivery System (TDS) drug delivery solutions to patients worldwide,” said Dr. Howard Lee, Chairman and CEO of TAHO Pharmaceuticals. “As the first ODF formulation in the anticoagulant space, TAH3311 has the potential to transform how these life-saving therapies are delivered, especially for patients who face difficulties with traditional tablet forms.”

*Source: www.pharmacompass.com

About Apixaban

Apixaban (co-developed by BMS and Pfizer under the brand name Eliquis®) is a direct factor Xa inhibitor and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement surgery, the treatment of deep vein thrombosis or pulmonary embolism, and prevention of recurrent deep vein thrombosis and pulmonary embolism. With notable safety advantages, it is the leading novel oral anticoagulant (NOAC). According to various industry reports, apixaban was the second-highest-selling drug globally in 2023.

About TAHO Pharmaceuticals Ltd.

Founded in 2010, TAHO Pharmaceuticals Ltd. leverages its proprietary Transepithelial Delivery System (TDS) to overcome the limitations of existing drugs and develop innovative dosage forms for niche markets. The TDS platform combines advanced transdermal and transmucosal delivery technologies, enabling the development of unique dosage forms such as transdermal patches, ODF, and buccal films. TAHO’s diverse product portfolio spans a variety of therapeutic areas, including antithrombotic agents, opioid overdose antidotes, addiction treatments, pediatric ADHD, and chemotherapy-induced antiemetics. Among its notable achievements, TAH4411, an ODF for chemotherapy-induced nausea and vomiting, became the first product of its kind to receive regulatory approval and be commercialized in Japan.